Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial
Clinical trial NCT07643103 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07643103
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-12
- Primary completion
- 2028-05-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.